Timothy van Hauwermeiren - 01 Nov 2023 Form 4 Insider Report for RayzeBio, Inc.

Role
Director
Signature
/s/ Jeff Woodley, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Nov 2023
Net transactions value
$0
Form type
4
Filing time
01 Nov 2023, 16:09:04 UTC
Previous filing
15 Jun 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYZB Stock Option (right to buy) Award $0 +48,628 $0.000000 48,628 01 Nov 2023 Common Stock 48,628 $20.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of 36 successive equal monthly installments over the three-year period measured from the date of grant.